Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07460518) titled 'Tranexamic Acid for Bleeding Reduction During TURP Surgery' on March 1.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).

Primary Sponsor: Hamza Najout

Condition: Benign Prostatic Hyperplasia Transurethral Resection of the Prostate Perioperative Bleeding Anemia, Postoperative

Intervention: Drug: Tranexamic Acid

Recruitment Status: Not recruiting

Phase: Phase 4

Date of First Enrollment: March 15, 2026

Target Sample Size: 80

Countries of Re...